Sunstar Butler announces new syringe for PerioGlas

Sunstar Butler today announced the availability of an easy-to-use 0.5cc syringe for dispensing PerioGlas Synthetic Bone Graft Material, a unique bioactive bone grafting particulate.

Proven in more than 700,000 cases worldwide, PerioGlas is safe and biocompatible and bonds to both bone and soft tissue. PerioGlas is clinically shown to regenerate bone as fast and as dense as demineralized freeze-dried bone allograft.

With better handling than autogenous bone and DFDBA, PerioGlas eliminates the need for second surgical sites required for autografts, thus reducing the risk of infection and patient discomfort. PerioGlas is more readily accepted by patients than animal-derived products, it and offers no risk of transgenic disease or rejection. PerioGlas also exhibits an antimicrobial effect on oral microorganisms.

PerioGlas is indicated for a variety of osseous defects, including ridge augmentation, sinus elevation, extraction sites, cystectomies and apicoectomies, and periodontal and peri-implant defects.

For more information, log on to www.jbutler.com.